James Fasano - Iqvia Holdings Director

<div class='circular--portrait' style='background:#0D52D1;color: white;font-size:5em;padding-top: 5px;;'>Q</div>
  Director
Mr. James A. Fasano serves as Independent Director of the Company. Prior to his role at the Company, Mr. Fasano served as a director of IMS Health from January 2015 until October 2016. He is Managing Director responsible for leading CPP Investment Boards Funds, Secondaries Coinvestments group and previously led CPPIBs Principal Investing group. Prior to joining CPPIB in 2004, Mr. Fasano worked in the Investment Banking group at Merrill Lynch Co., focusing on companies in the media and telecommunications sectors. Previously, he was a member of the Mergers Acquisitions group at RBC Capital Markets and was a Commissioned Officer in the Canadian Armed Forces. Mr. Fasano serves on the board of directors of NEWAsurion, and formerly was a director of Cequel Communications, AWAS Aviation Capital, LHP Hospital Group and Kinetic Concepts. He holds a Bachelor of Engineering degree from the Royal Military College of Canada and an M.B.A. from the University of Chicago Graduate School of Business. Mr. Fasano chairs the Audit Committee.
Age: 46  Director Since 2016  MBA    
919-998-2000  www.quintiles.com
Fasano serves on the board of directors of NEWAsurion, and formerly was a director of Cequel Communications, AWAS Aviation Capital, LHP Hospital Group and Kinetic Concepts. He holds a Bachelor of Engineering degree from the Royal Military College of Canada and an M.B.A. from the University of Chicago Graduate School of Business.

Management Efficiency

The company has return on total asset of 4.03 % which means that for every 100 dollars spent on asset it generated profit of $4.03. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 1.89 % implying that it made 1.89 on every $100 invested by shareholders.
The company has accumulated 9.77 B in total debt with debt to equity ratio (D/E) of 130.0 implying that the company may be unable to produce cash to meet its debt commitments. Iqvia Holdings has Current Ratio of 1.2 implying that it may have difficulties to pay its interest payments when they become due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Tsunehisa OkunoNIPPON TEL TEL CORP
2018
Jong KimSK Innovation
N/A
Katsuhiko KawazoeNIPPON TEL TEL CORP
2018
Danilo SilvaPETROBRAS PN N2
2018
Guilherme FerreiraPETROBRAS PN N2
2015
Myeong LeeSK Innovation
2019
Jeong YuSK Innovation
2016
Hiroshi TsujigamiNIPPON TEL TEL CORP
2012
Eiichi SakamotoNIPPON TEL TEL CORP
2018
Eiichi SakamotoNIPPON TEL TEL CORP
2018
Jeronimo AntunesPETROBRAS PN N2
2019
Betania CoutinhoPETROBRAS PN N2
2016
Min HahnSK Innovation
2015
Min HanSK Innovation
2015
Katsuhiko ShiraiNIPPON TEL TEL CORP
2012
Dae KimSK Innovation
2015
Hyeok ChoiSK Innovation
2010
Clarissa LinsPETROBRAS PN N2
N/A
Durval SantosPETROBRAS PN N2
2016
Deyvid SilvaPETROBRAS PN N2
2015
Yeong KimSK Innovation
2010

Entity Summary

Quintiles IMS Holdings, Inc. offer biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the AsiaPacific. Iqvia Holdings (Q) is traded on BATS Exchange in USA and employs 36,100 people.

Iqvia Holdings Leadership Team

Thomas Pike, CEO and Director
Ari Bousbib, Director
Michael Evanisko, Independent Director
Leonard Schaeffer, Independent Director
James Erlinger, Executive Vice President General Counsel, Secretary
John Danhakl, Director
Richard Staub, President - Research and Development Solutions
Michael McDonnell, CFO, Executive Vice President
Kevin Gordon, COO
John Leonard, Independent Director
James Fasano, Director
Jonathan Coslet, Director
John Connaughton, Director
Haiyuan Lo, Director
Ronald Rittenmeyer, Director
Dennis Gillings, Executive Chairman of the Board
Todd Sisitsky, Director
Jack Greenberg, Independent Director
Kevin Knightly, President - Information and Technology Solutions

Stock Performance Indicators

Current Sentiment - Q

Iqvia Holdings Investor Sentiment

More than half of Macroaxis users are at this time bullish on Iqvia Holdings. What is your judgment towards investing in Iqvia Holdings? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

USRT   
Purchased few shares of
a day ago
Traded for 55.68
IJR   
Purchased few shares of
a day ago
Traded for 85.37
IJH   
Purchased one share of
a day ago
Traded for 209.15
IVV   
Purchased one share of
a day ago
Traded for 333.5
IDEV   
Purchased few shares of
a day ago
Traded for 59.01
See also Your Equity Center. Please also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.